Abstract

Pediatric Compounding: Coloring Outside the Lines

Author(s): Preckshot John

Issue: Jan/Feb 2001 - Compounding for Pediatric Patients

Page(s): 6-8

Download in electronic PDF format for $75

Abstract

Most new drugs are not labeled for certain populations, such as infants and children; and “off-label” use of drugs is common in pediatric patients. In this article, the author introduces pediatricians to the services of compounding pharmacists. He discusses topical anesthetic combinations, laxative formulations, medications for attention-deficit hyperactivity disorder, antinausea medications, diaper-rash medications, acne medications and head -ice medications. He concludes that the compounding pharmacist must use innovative thinking to formulate pediatric titrations of adult medications and to flavor those titrations to make them more palatable for children.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2001 Pg. 6-8	Pediatric Compounding: Coloring Outside the Lines Author(s): Preckshot John
May/Jun 2016 Pg. 247-249	Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Author(s): Nahata Milap C
Jan/Feb 2001 Pg. 9-12	Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Author(s): Schotik Debora
Jan/Feb 2004 Pg. 10-14	Women's Oral Health: Is There a Hormonal Link? Author(s): Preckshot John
Jan/Feb 2007 Pg. 26-27	Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis Author(s): Fields Shannon W
Jul/Aug 2024 Pg. 282-285	Pediatric Compounding: Coloring Outside the Lines Author(s): Preckshot John
Jul/Aug 2019 Pg. 324-331	Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients Author(s): de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro
Jan/Feb 2010 Pg. 32-38	Unit Dose Packaging and Repackaging of Solid and Liquid Dosage Forms in an Institutional Setting Author(s): McElhiney Linda F
Jul/Aug 2006 Pg. 300	Dapsone 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 386-388	Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder Author(s): Gupta Vishnu D
Nov/Dec 2005 Pg. 437-442	Pediatric Oral Liquid Preparations Author(s): Fonseca Simonne C, Ferreira Anderson de O
Jan/Feb 2001 Pg. 65-67	Oral Liquid Vehicles, Featured Excipient: Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 385	Indinavir 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 445-446	Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms Author(s): Gupta Vishnu D
Mar/Apr 2005 Pg. 165-166	Chemical Stability of Isoniazid in an Oral Liquid Dosage Form Author(s): Gupta Vishnu D, Sood Arun
Jan/Feb 2007 Pg. 17-19	Pediatric Oral Formulations: A Continual Challenge Author(s): Hurtado Josephine, Moffett Brady S
Jul/Aug 2008 Pg. 372-374	Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms Author(s): Gupta Vishnu D
Sep/Oct 2021 Pg. 415	Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 456-461	Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Author(s): Fonseca Simonne C
May/Jun 2000 Pg. 233-235	Stability of an Oral Liquid Dosage Form of Trovafloxacin Mesylate and Its Quantitation in Tablets Using High-Performance Liquid Chromatography Author(s): Gupta Vishnu D